Lifeboat Foundation

Step two of…

(Meanwhile in Bangladesh)

The ID2020 Alliance has launched a new digital identity program at its annual summit in New York, in collaboration with the Government of Bangladesh, vaccine alliance Gavi, and new partners in government, academia, and humanitarian relief.

Continue reading “ID2020 and partners launch program to provide digital ID with vaccines” »

Shane chats with former NSA spy and whistleblower Edward Snowden on the rise of authoritarianism during the COVID-19 pandemic.

About VICE:
The Definitive Guide To Enlightening Information. From every corner of the planet, our immersive, caustic, ground-breaking and often bizarre stories have changed the way people think about culture, crime, art, parties, fashion, protest, the internet and other subjects that don’t even have names yet. Browse the growing library and discover corners of the world you never knew existed. Welcome to VICE.

Continue reading “Shelter in Place with Shane Smith & Edward Snowden (Full Episode)” »

Apple Inc. and Google unveiled a rare partnership to add technology to their smartphone platforms that will alert users if they have come into contact with a person with Covid-19. People must opt in to the system, but it has the potential to monitor about a third of the world’s population.

The role of automatic electrocardiogram (ECG) analysis in clinical practice is limited by the accuracy of existing models. Deep Neural Networks (DNNs) are models composed of stacked transformations that learn tasks by examples. This technology has recently achieved striking success in a variety of task and there are great expectations on how it might improve clinical practice. Here we present a DNN model trained in a dataset with more than 2 million labeled exams analyzed by the Telehealth Network of Minas Gerais and collected under the scope of the CODE (Clinical Outcomes in Digital Electrocardiology) study. The DNN outperform cardiology resident medical doctors in recognizing 6 types of abnormalities in 12-lead ECG recordings, with F1 scores above 80% and specificity over 99%. These results indicate ECG analysis based on DNNs, previously studied in a single-lead setup, generalizes well to 12-lead exams, taking the technology closer to the standard clinical practice.

Amid the coronavirus pandemic that has spread across the U.S., a number of states have extended their lockdown orders in an effort to combat the spread of the virus.

As of April 8, every U.S. state has reported confirmed coronavirus cases but the stay-at-home and shelter-in-place policies all came at different times. California was the first state to issue a stay-at-home order on March 19, while South Carolina was the most recent, issuing their statewide order on April 7. Some other states like Arkansas, Iowa, North Dakota and Nebraska have yet to issue statewide stay-at-home orders.

The new viruses are not harmful to humans or closely related to SARS-CoV-2, the coronavirus that causes COVID-19.

Researchers at the Hebrew University of Jerusalem announced on Sunday that they have developed a new method of testing for COVID-19 which is not only 4–10 times faster than the tests most commonly used today, but also significantly cheaper, while supplying the same level of accuracy. Moreover, most of the materials required to perform the new test are already available in Israel, easing significantly both the country’s dire shortage of testing materials and its heavy economic dependence on foreign commercial markets. The method was developed in the labs of Prof. Nir Friedman of the Institute of Life Sciences and the School of Engineering and Computer Sciences and Dr. Naomi Haviv of Hebrew University’s Neuroscience Research Center, and is based on materials which are not affected by global shortages and can be recycled for repeated used on future tests. The method commonly used today for COVID-19 testing involves extracting RNA molecules from a patient’s sample to determine if the molecules produced have viral RNA within them, which confirms the presence of the coronavirus. The new test developed by the researchers performs the same action, but is made from more commonly attainable materials, that produce results at a much higher speed. Dr. Naomi Haviv said that “We have an efficient RNA extraction method, 4–10 times faster than the current method. It is based on magnetic beads and can be performed both robotically and manually.”

Other than the magnetic beads, all of the other materials needed to perform the tests are available for purchase in Israel. The beads themselves are recyclable and can be reused to perform future tests. “The robotic method has already undergone a series of tests at Hadassah Hospital, using hundreds of samples from patients — and is now becoming operational.”

Continue reading “Israeli researchers at Hebrew U develop faster, cheaper COVID-19 test” »

At least 70 potential coronavirus vaccines are currently in development, with 3 already in clinical trials, according to the World Health Organisation.

WHO published an updated list of vaccine efforts on April 11, showing a vast array of companies pursuing shots that could halt the coronavirus. Bloomberg News reported on the document earlier.

As the virus continues to spread, infecting more than 1.9 million people and killing more than 110,000 worldwide, researchers have been racing to develop vaccines.